BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21221823)

  • 1. The impact of insulin resistance and hyperandrogenemia on polysomnographic variables in obese adolescents with polycystic ovarian syndrome.
    de Sousa G; Schlüter B; Buschatz D; Menke T; Trowitzsch E; Andler W; Reinehr T
    Sleep Breath; 2012 Mar; 16(1):169-75. PubMed ID: 21221823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal analyses of polysomnographic variables, serum androgens, and parameters of glucose metabolism in obese adolescents with polycystic ovarian syndrome.
    de Sousa G; Schlüter B; Menke T; Trowitzsch E; Andler W; Reinehr T
    Sleep Breath; 2012 Dec; 16(4):1139-46. PubMed ID: 22102291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between polysomnographic variables, parameters of glucose metabolism, and serum androgens in obese adolescents with polycystic ovarian syndrome.
    de Sousa G; Schlüter B; Menke T; Trowitzsch E; Andler W; Reinehr T
    J Sleep Res; 2011 Sep; 20(3):472-8. PubMed ID: 21199038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of polysomnographic variables between adolescents with polycystic ovarian syndrome with and without the metabolic syndrome.
    de Sousa G; Schlüter B; Menke T; Trowitzsch E; Andler W; Reinehr T
    Metab Syndr Relat Disord; 2011 Jun; 9(3):191-6. PubMed ID: 21352077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of polysomnographic variables between obese adolescents with polycystic ovarian syndrome and healthy, normal-weight and obese adolescents.
    de Sousa G; Schlüter B; Buschatz D; Menke T; Trowitzsch E; Andler W; Reinehr T
    Sleep Breath; 2010 Feb; 14(1):33-8. PubMed ID: 19585163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of insulin resistance and its relationship with hyperandrogenemia,anti-Müllerian hormone, inhibin A, inhibin B, and insulin-like peptide-3 levels in adolescent girls with polycystic ovary syndrome.
    Yetim Şahin A; Baş F; Yetim Ç; Uçar A; Poyrazoğlu Ş; Bundak R; Darendeliler F
    Turk J Med Sci; 2019 Aug; 49(4):1117-1125. PubMed ID: 31286756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
    Pasquali R; Patton L; Pocognoli P; Cognigni GE; Gambineri A
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep disorders in polycystic ovary syndrome: influence of obesity and hyperandrogenism.
    Hachul H; Polesel DN; Tock L; Carneiro G; Pereira AZ; Zanella MT; Tufik S; Togeiro SM
    Rev Assoc Med Bras (1992); 2019 Mar; 65(3):375-383. PubMed ID: 30994836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients.
    Liao Y; Huang R; Sun Y; Yue J; Zheng J; Wang L; Tao T; Ma J; Li S; Liu W
    Reprod Biol Endocrinol; 2017 Jan; 15(1):9. PubMed ID: 28125989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of the free androgen index depends on the phenotype of polycystic ovary syndrome - a single-centre experience.
    Ożga K; Krzyczkowska-Sendrakowska M; Hubalewska-Dydejczyk A; Gilis-Januszewska A; Ratajczak M; Ratajczak M; Chaykivska Z; Jach R
    Endokrynol Pol; 2019; 70(4):330-335. PubMed ID: 30938834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep and cardiometabolic function in obese adolescent girls with polycystic ovary syndrome.
    Nandalike K; Agarwal C; Strauss T; Coupey SM; Isasi CR; Sin S; Arens R
    Sleep Med; 2012 Dec; 13(10):1307-12. PubMed ID: 22921588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance.
    Vgontzas AN; Legro RS; Bixler EO; Grayev A; Kales A; Chrousos GP
    J Clin Endocrinol Metab; 2001 Feb; 86(2):517-20. PubMed ID: 11158002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome.
    Alemzadeh R; Kichler J; Calhoun M
    Eur J Endocrinol; 2010 Jun; 162(6):1093-9. PubMed ID: 20371657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
    Dewailly D; Pigny P; Soudan B; Catteau-Jonard S; Decanter C; Poncelet E; Duhamel A
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4399-405. PubMed ID: 20610596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women.
    Mokhlesi B; Scoccia B; Mazzone T; Sam S
    Fertil Steril; 2012 Mar; 97(3):786-91. PubMed ID: 22264851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome.
    Enli Y; Fenkci SM; Fenkci V; Oztekin O
    Gynecol Endocrinol; 2013 Dec; 29(12):1036-9. PubMed ID: 23961784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance, obesity, hypofibrinolysis, hyperandrogenism, and coronary heart disease risk factors in 25 pre-perimenarchal girls age < or =14 years, 13 with precocious puberty, 23 with a first-degree relative with polycystic ovary syndrome.
    Glueck CJ; Morrison JA; Wang P
    J Pediatr Endocrinol Metab; 2008 Oct; 21(10):973-84. PubMed ID: 19209619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin sensitivity in women with polycystic ovary syndrome: relationship to hyperandrogenemia.
    Rajkhowa M; Bicknell J; Jones M; Clayton RN
    Fertil Steril; 1994 Apr; 61(4):605-12. PubMed ID: 8150099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.